What Are Hub Services in Specialty Pharmacy?

Hub services are support programs, typically funded by pharmaceutical manufacturers, that act as a single point of contact between patients, doctors, specialty pharmacies, and insurers. Their core purpose is to help patients access complex or expensive medications by handling the logistical and financial hurdles that often stand between a prescription and actual treatment. They originated as call-center-style operations offering financial assistance, but have expanded into comprehensive programs covering insurance navigation, medication delivery coordination, and ongoing adherence support.

How Hub Services Work

When a doctor prescribes a specialty medication, the path to actually receiving that drug can be surprisingly complicated. Insurance needs to verify coverage, prior authorizations may be required, the drug might only be available through certain pharmacies, and the patient may face costs running into thousands of dollars per month. A hub service centralizes all of this. Instead of a doctor’s office calling multiple pharmacies and insurers, they contact one hub that manages the entire process.

Hubs serve as go-betweens for manufacturers and specialty pharmacies, giving physicians a single contact to get a medication filled rather than tracking down which pharmacy carries a particular drug. They also give patients a consistent experience regardless of where their prescription is ultimately dispensed.

Core Functions

Hub services perform four broad categories of work:

  • Reimbursement services: This includes verifying a patient’s insurance benefits, determining what’s covered, and managing prior authorizations with the insurer. For drugs billed through pharmacy benefits, much of this can be handled electronically. For medications billed as medical procedures (like infusions administered in a clinic), the process still relies heavily on phone calls to confirm coverage.
  • Financial assistance: Hubs connect patients with copay cards funded by the manufacturer, charitable foundation grants, or other programs that reduce out-of-pocket costs. This is one of the oldest functions hubs provide and often the reason patients first interact with one.
  • Distribution coordination: The hub aggregates specialty pharmacies and routes prescriptions to ensure the medication reaches the patient. This simplifies things for doctors, who don’t need to know which specialty pharmacy stocks which drug.
  • Adherence and clinical monitoring: Because specialty medications treat serious conditions and are expensive, staying on therapy matters. Hubs track whether patients are refilling on time, check in with them, and report outcomes back to the manufacturer. Preventing therapy abandonment is one of the principal goals of any hub program.

Which Medications Use Hub Services

Hub services are most common with specialty drugs, the category of medications used to treat complex, chronic, or rare conditions. These are drugs for diseases like cancer, rheumatoid arthritis, multiple sclerosis, hemophilia, and rare genetic disorders. What these therapies have in common is high cost (often thousands of dollars per dose), complicated administration (injections, infusions, or strict dosing schedules), and a limited network of pharmacies that can dispense them.

A hub’s revenue typically comes from providing services around a single product or a small portfolio from one manufacturer. This narrow focus means hub staff develop deep expertise in the specific insurance landscape, side effect profile, and patient needs associated with that drug. Specialty pharmacies, by contrast, support many products across multiple therapeutic areas, though larger ones often dedicate specific teams to individual disease categories and can offer a similar depth of support.

Hubs vs. Specialty Pharmacies

This distinction trips people up because the two overlap. A specialty pharmacy dispenses medications and provides clinical support to patients taking them. A hub doesn’t dispense anything. It sits one layer above, coordinating between the prescriber, the insurer, the specialty pharmacy, and the patient. Think of the hub as the project manager and the specialty pharmacy as one of the contractors doing the hands-on work.

In practice, some specialty pharmacies offer hub-like services internally, and some hub providers have built out pharmacy capabilities. The lines blur. But the traditional split is clear: hubs manage access and logistics, pharmacies manage dispensing and clinical care.

Technology Behind Modern Hubs

Hubs have moved well beyond phone-based call centers. Benefits investigation and prior authorization, two of the most time-consuming steps in getting a specialty drug approved, are increasingly handled through electronic platforms. Tools like CoverMyMeds allow prior authorizations to be submitted and tracked digitally, cutting days off the process. Electronic benefits verification can be integrated directly into the hub’s workflow systems, so a patient’s coverage status is confirmed almost instantly for pharmacy-billed drugs.

Many hubs now offer online portals where doctors and their staff can check the real-time status of a patient’s case: where the prior authorization stands, whether the drug has shipped, when the next refill is due. These portals work best for drugs with large patient populations. For rare disease programs where a doctor might have only one or two patients on a given therapy, the portal sees less use and direct phone communication remains more practical.

Multilingual support has also become standard. Most hubs use language line services that offer interpretation in over 240 languages, removing a barrier that could otherwise delay or derail a patient’s access to treatment. Artificial intelligence is starting to enter the space as well, with potential to speed up routine tasks like call routing and case documentation.

Regulatory Guardrails

Because hub services are funded by drug manufacturers, they operate under close regulatory scrutiny. The main concern is that support services could cross the line into improper incentives, essentially paying to influence prescribing decisions. Federal anti-kickback rules apply directly here.

The Office of Inspector General has outlined the boundaries. Basic support services tied to a manufacturer’s own product, like helping a patient navigate reimbursement, are generally acceptable as long as they don’t confer a financial benefit on the prescribing doctor. But if a manufacturer were to bundle reimbursement support with, say, a guarantee that the doctor only pays for the drug if insurance reimburses them, that arrangement would raise serious legal concerns. The key distinction is whether the hub service has independent value to the patient versus whether it’s structured to reward or protect the prescriber financially.

Hub programs must be carefully designed to stay on the right side of these rules, which is why most manufacturers work with compliance teams and outside counsel when building or modifying their hub offerings.